Jaguar Health, Inc.

JAGX · Nasdaq · SIC 2834: Pharmaceutical Preparations
447
SEC Filings

Business Summary

1 Item 1A. Risk Factors 35 Item 1B. Unresolved Staff Comments 69 Item 1C. Cybersecurity 69 Item 2. Properties 70 Item 3. Legal Proceedings 70 Item 4. Mine Safety Disclosure 70 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 71 Item 6. Selected Financial Data 72 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 73 Item 7A. Qualitative and Quantitative Disclosures About Market Ris...

Next Earnings

Q2 FY2026 — expected 2026-09-18

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionJAGXdiscussed_in_filing Cybersecurity
topic_mentionJAGXdiscussed_in_filing Cybersecurity
topic_mentionJAGXdiscussed_in_filing Cybersecurity
topic_mentionJAGXdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-03-312024-12-310000950170-25-047184EDGAR105K words
2024-04-012023-12-310001558370-24-004439EDGAR—
2023-03-242022-12-310001558370-23-004572EDGAR—
2022-03-112021-12-310001558370-22-003435EDGAR—
2021-03-312020-12-310001558370-21-003811EDGAR—
2020-04-032019-12-310001558370-20-003581EDGAR—
2019-04-102018-12-310001558370-19-002908EDGAR—
2018-04-092017-12-310001047469-18-002654EDGAR—
2017-02-152016-12-310001047469-17-000684EDGAR—
2016-03-292015-12-310001047469-16-011700EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001193125-25-282950EDGAR58K words
2025-08-142025-06-300000950170-25-108393EDGAR—
2025-05-152025-03-310000950170-25-072367EDGAR—
2024-11-132024-09-300000950170-24-125916EDGAR—
2024-08-132024-06-300001558370-24-011971EDGAR—
2024-05-142024-03-310001558370-24-008050EDGAR—
2023-11-142023-09-300001558370-23-018909EDGAR—
2023-08-142023-06-300001558370-23-014683EDGAR—
2023-05-152023-03-310001558370-23-009695EDGAR—
2022-11-142022-09-300001558370-22-017547EDGAR—
2022-08-222022-06-300001558370-22-013831EDGAR—
2022-05-102022-03-310001558370-22-007961EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-090001193125-26-097700EDGAR5K words
2026-03-060001193125-26-096565EDGAR—
2026-03-030001193125-26-086882EDGAR—
2026-02-180001193125-26-056157EDGAR—
2026-01-230001193125-26-021064EDGAR—
2026-01-150001193125-26-014231EDGAR—
2026-01-120001193125-26-009644EDGAR—
2026-01-120001193125-26-009221EDGAR—
2025-12-120001193125-25-317693EDGAR—
2025-12-080001193125-25-311294EDGAR—

447 total filings indexed. 415 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001585608
TickerJAGX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f2e0d6d01c3a649ea426645b6c9ff99dfd306ef7bf55d5a11bbf5dd36504314a
parent: 93ddee0e0ec3deca52764ab80efb145bb5f0a45c09fc3fa88cfb941ac5a53e4e
content hash: 5d43db26ab1b7035396b65669389eb9070444586d253220ab77be8a4cf60f4fa
signed: 2026-04-13T04:45:47.359Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf